Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug.
Abbott on Wednesday announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose-sensing technology for people with diabetes.
Teva Pharmaceutical on Wednesday announced that a positive judgment has been given by the U.K. High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.
Traditional Medicinals herbal supplement wellness teas have chosen to partner with the RealCup brand for their launch into the fast-growing single-serve capsule format, the company announced last week.